Trademark: 90554690
Word
HEMERION
Status
Pending
Status Code
733
Status Date
Friday, January 19, 2024
Serial Number
90554690
Mark Type
4000
Filing Date
Tuesday, March 2, 2021
Published for Opposition
Tuesday, November 30, 2021

Trademark Owner History
HEMERION THERAPEUTICS - Owner At Publication

Classifications
5 (Based on Intent to Use) Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical, medical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Dietetic food, dietetic beverages, and dietetic preparations adapted for medical and veterinary purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology
10 (Based on 44(e)) Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus, medical devices for detecting and treating cancer, x-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatus, specifically, implantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes
42 (Based on 44(e)) Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing services, specifically, in vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; medical, pharmacological, biological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research services, namely, performance of biological, chemical and pharmacological analyses of pharmaceutical products

Trademark Events
Jan 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2024
Sou Extension 4 Granted
Jan 19, 2024
Sou Extension 4 Filed
Jan 19, 2024
Sou Teas Extension Received
Jul 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2023
Sou Extension 3 Granted
Jul 20, 2023
Sou Extension 3 Filed
Jul 20, 2023
Sou Teas Extension Received
Jan 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2023
Sou Extension 2 Granted
Jan 11, 2023
Sou Extension 2 Filed
Jan 11, 2023
Sou Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 1 Granted
Jun 27, 2022
Sou Extension 1 Filed
Jun 27, 2022
Sou Teas Extension Received
Jan 25, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 30, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 30, 2021
Published For Opposition
Nov 10, 2021
Notification Of Notice Of Publication E-Mailed
Oct 28, 2021
Electronic Record Review Complete
Oct 22, 2021
On Hold - Electronic Record Review Required
Oct 21, 2021
Approved For Pub - Principal Register
Oct 21, 2021
Examiner's Amendment Entered
Oct 21, 2021
Notification Of Examiners Amendment E-Mailed
Oct 21, 2021
Examiners Amendment E-Mailed
Oct 21, 2021
Examiners Amendment -Written
Sep 28, 2021
Notification Of Non-Final Action E-Mailed
Sep 28, 2021
Non-Final Action E-Mailed
Sep 28, 2021
Non-Final Action Written
Sep 22, 2021
Assigned To Examiner
Jun 1, 2021
New Application Office Supplied Data Entered
Mar 5, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24